Filling the need for trusted information on national health issues…

Gilead Sciences To Donate $8M In Visceral Leishmaniasis Drug To WHO

Gilead Sciences, Inc. “will donate 445,000 vials of AmBisome over five years to help the World Health Organization (WHO) treat more than 50,000 patients with visceral leishmaniasis (VL), also known as kala-azar,” a Gilead press release states, adding, “If sold at Gilead’s no-profit access price, today’s donation would cost more than $8 million.” According to the press release, the initiative is “part of the Gilead Access Program, which aims to provide wider access to the company’s medications to affected populations in the developing world” (12/8).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.